CLS Newsletters
Stay up to date on Chemical and Life Science law by reading the Quarterly CLS Newsletters at the links below.
TO READ THE LATEST ISSUE CLICK HERE
Q3 2025
– USPTO Ends Accelerated Examination for Utility Patents
– USPTO Raises Track One Annual Limit
– USPTO Resumes In Person PTAB Hearings
– USPTO Unveils DesignVision AI Tool to Enhance Design Patent Searches
CASE LAW UPDATES
– Regents of the University of California v. Broad Institute, Inc., Nos. 2022‑1594, 2022‑1653 (Fed. Cir. 2025)
– Alnylam Pharms., Inc. v. Moderna, Inc., 138 F.4th 1326 (Fed. Cir. 2025)
– Eye Therapies, LLC v. Slayback Pharma, LLC, 141 F.4th 1264 (Fed. Cir. 2025)
IPO RESOLUTION
– IPO Opposes “Skinny Labels, Big Savings Act”
NEW ARTICLE
– Navigating Patent Term Adjustment And Patent Term Extension: Recent Court Rulings And Their Impact On Obviousness-Type Double Patenting
CLS PRACTICE GROUP UPDATES
– Upcoming Conferences
Q2 2025
USPTO UPDATES
– Fewer IPR petitions likely to be granted under Fintiv
– USPTO Updates Patents Dashboard
– USPTO Expediting Patent Issuance Process
– USPTO formally terminates Climate Change Mitigation Pilot Program
– USPTO discontinuing Accelerated Examination program for
utility applications
CASE LAW UPDATES
– US Synthetic v. ITC, 128 F.4th 1272, 1287 (Fed. Cir. 2025)
– In re Xencor, Inc., 130 F.4th 1350 (Fed. Cir. 2025)
– Agilent Technologies, Inc. v. Synthego Corp., Nos. 2023-2186, 2023-2187 (Fed. Cir. June 11, 2025)
HOW TO MAXIMIZE PATENT TERM ADJUSTMENT (PTA)
CLS PRACTICE GROUP UPDATES
– Information On Harness IP’s CLS Practice Group And Upcoming Conferences
Q1 2025
WHAT TO EXPECT
- Expert analysis on chemical and life science-related IP issues
- Key patent and trademark developments
- Trends shaping the future of the industry
- Practical tips and strategies for IP management Stay informed and ahead of the curve.
SUBSCRIBE and get the latest insights delivered directly to your inbox!